Related Experiment Video

Updated: Aug 29, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

Colistin for Klebsiella pneumoniae-associated sepsis

A Karabinis1, E Paramythiotou, D Mylona-Petropoulou

  • 1Intensive Care Unit, General Hospital of Athens, George Gennimatas, Athens, Greece.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|December 18, 2003
PubMed

Insights

A multidrug-resistant Klebsiella pneumoniae strain, impervious to all antibiotics including carbapenems, was identified in an intensive care unit patient. Colistin effectively treated the resulting septic shock, highlighting its role in managing pan-resistant infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Critical Care Medicine

Background:

  • Emergence of multidrug-resistant (MDR) bacteria poses a significant threat in healthcare settings.
  • Klebsiella pneumoniae is a common cause of hospital-acquired infections, with increasing resistance to antibiotics.
  • Carbapenem resistance in Klebsiella pneumoniae is a major global health concern.

Purpose of the Study:

  • To report a case of septic shock caused by pan-resistant Klebsiella pneumoniae.
  • To highlight the clinical challenge of treating infections with limited therapeutic options.
  • To emphasize the efficacy of colistin in managing such critical cases.

Main Methods:

  • Isolation and antibiotic susceptibility testing of Klebsiella pneumoniae from patient blood samples.
  • Clinical monitoring and management of septic shock.
  • Retrospective analysis of treatment outcomes.

Main Results:

  • A Klebsiella pneumoniae isolate exhibited resistance to all tested antibiotics, including carbapenems (imipenem MIC = 32 microg/mL).
  • The patient presented with and was treated for septic shock.
  • Successful treatment of septic shock was achieved using colistin.

Conclusions:

  • Colistin remains a vital therapeutic option for infections caused by pan-resistant Klebsiella pneumoniae.
  • Vigilant surveillance and appropriate antibiotic stewardship are crucial in combating antimicrobial resistance.
  • This case underscores the importance of preserving last-resort antibiotics like colistin.

More Related Videos

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: